Skip to main content
Atrás
Watch Compare

Cabaletta Bio, Inc.

Calidad de datos: 83%
CABA
Nasdaq Manufacturing Chemicals
$3.10
▲ $0.01 (0.32%)
Cap. Mercado: 345.10 M
Precio
$3.10
Cap. Mercado
345.10 M
Rango del Día
$3.04 — $3.22
Rango de 52 Semanas
$1.04 — $3.78
Volumen
1,421,315
Apertura $3.07
Promedio 50D / 200D
$2.94
5.51% above
Promedio 50D / 200D
$2.30
34.77% above

Quick Summary

Puntos Clave

Negative free cash flow of -132.31 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-105.59%
Below sector avg (-53.41%)
ROIC-83.23%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio3.60
Interest Coverage-85.95

Valoración

PE (TTM)
-2.06
Below sector avg (-1.48)
P/B Ratio2.47
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -2.1 -1.5
P/B 2.5 1.6
ROE % -105.6 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -167.86 M
ROE -105.59% ROA -81.04%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -132.31 M
ROIC -83.23% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3.60
Interest Coverage -85.95 Asset Turnover N/A
Working Capital 118.83 M Tangible Book Value 139.47 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.06 Forward P/E N/A
P/B Ratio 2.47 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -38.34%
Market Cap 345.10 M Enterprise Value 284.89 M
Per Share
EPS (Diluted TTM) -2.10 Revenue / Share N/A
FCF / Share -1.19 OCF / Share -1.18
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 78.82%
SBC-Adj. FCF -154.24 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -167.86 M -115.86 M -67.68 M -52.98 M -46.29 M
EPS (Diluted) -2.10 -2.34 -1.65 -1.81 —
Gross Profit — — — — —
Operating Income -172.24 M -125.14 M -74.66 M -54.14 M -46.31 M
EBITDA — — — — —
R&D Expenses 142.67 M 97.20 M 55.42 M 39.30 M 32.49 M
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 2.00 M 748,000.0 — — —
Income Tax 0.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 165.08 M 185.05 M 253.65 M 116.97 M 126.34 M
Total Liabilities 53.03 M 32.71 M 17.45 M 12.45 M —
Shareholders' Equity 112.05 M 152.34 M 236.20 M 104.52 M 117.96 M
Total Debt — — — — —
Cash & Equivalents 82.98 M 163.96 M 193.24 M 81.61 M 122.22 M
Current Assets 138.87 M 166.68 M 244.49 M 108.83 M 124.54 M
Current Liabilities 50.15 M 27.09 M 15.99 M 9.49 M 8.38 M